Announced $10 million from options exercised in NAL plus the immunology float proceeds - over $20m in the group. This on top of devices starting to produce sales (announced earlier this week - $14 mill forecast for 2004/5). Delivering the goods!
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held